PAUL LING to Epstein-Barr Virus Nuclear Antigens
This is a "connection" page, showing publications PAUL LING has written about Epstein-Barr Virus Nuclear Antigens.
Connection Strength
2.803
-
The EBNA-2 N-Terminal Transactivation Domain Folds into a Dimeric Structure Required for Target Gene Activation. PLoS Pathog. 2015 May; 11(5):e1004910.
Score: 0.492
-
EBNA2 and Its Coactivator EBNA-LP. Curr Top Microbiol Immunol. 2015; 391:35-59.
Score: 0.479
-
Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100. EMBO J. 2005 Oct 19; 24(20):3565-75.
Score: 0.252
-
The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter. J Virol. 2005 Apr; 79(7):4492-505.
Score: 0.243
-
EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance. J Virol. 2004 Apr; 78(8):3919-29.
Score: 0.227
-
The EBNA2 polyproline region is dispensable for Epstein-Barr virus-mediated immortalization maintenance. J Virol. 2002 Jul; 76(14):7349-55.
Score: 0.201
-
Notch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus. J Virol. 2001 Jul; 75(13):5899-912.
Score: 0.188
-
Conserved regions in the Epstein-Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2. J Virol. 2000 Nov; 74(21):9953-63.
Score: 0.179
-
Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation. J Virol. 1998 Jan; 72(1):693-700.
Score: 0.147
-
EBNA2 is required for protection of latently Epstein-Barr virus-infected B cells against specific apoptotic stimuli. J Virol. 2004 Nov; 78(22):12694-7.
Score: 0.059
-
Expression of Epstein-Barr virus latent genes in oral epithelium: determinants of the pathogenesis of oral hairy leukoplakia. J Infect Dis. 2004 Jul 15; 190(2):396-9.
Score: 0.058
-
Regulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway. J Virol. 2000 Sep; 74(17):8166-75.
Score: 0.044
-
Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses. J Virol. 2000 Jan; 74(1):379-89.
Score: 0.042
-
First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus. mBio. 2019 09 17; 10(5).
Score: 0.041
-
Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJk. J Virol. 1995 Mar; 69(3):1944-50.
Score: 0.030
-
EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. J Virol. 1994 Sep; 68(9):5375-83.
Score: 0.029
-
The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. Proc Natl Acad Sci U S A. 1993 Oct 15; 90(20):9237-41.
Score: 0.028
-
EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif. J Virol. 1993 Jun; 67(6):2990-3003.
Score: 0.027
-
Evolution of two types of rhesus lymphocryptovirus similar to type 1 and type 2 Epstein-Barr virus. J Virol. 1999 Nov; 73(11):9206-12.
Score: 0.010
-
Transcriptional activation signals found in the Epstein-Barr virus (EBV) latency C promoter are conserved in the latency C promoter sequences from baboon and Rhesus monkey EBV-like lymphocryptoviruses (cercopithicine herpesviruses 12 and 15). J Virol. 1999 Jan; 73(1):826-33.
Score: 0.010
-
Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial. Mol Cell Biol. 1995 Nov; 15(11):6150-9.
Score: 0.008
-
Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science. 1994 Jul 01; 265(5168):92-5.
Score: 0.007